Cargando…
Efficacy and safety of Jian-Pi Huo-Xue granule for non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled trial
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent form of chronic liver disease, with a global prevalence of 25% worldwide, but a consensus treatment is still lacking. Previous studies have shown that Jian-Pi Huo-Xue granules (JPHX) can reduce hepatic steatosis in u...
Autores principales: | Sun, Yuanlong, Chen, Gaofeng, Chen, Si, Wang, Yanjie, Hu, Yiyang, Zhao, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164345/ https://www.ncbi.nlm.nih.gov/pubmed/35655225 http://dx.doi.org/10.1186/s13063-022-06393-8 |
Ejemplares similares
-
Efficacy and safety of Qushi Huayu granule for hyperlipidemia: study protocol for a randomized, double-blind, placebo-controlled trial
por: Sun, Yuanlong, et al.
Publicado: (2022) -
Mechanisms and Molecular Targets of BuShenHuoXue Formula
for Osteoarthritis
por: Xiong, Wen, et al.
Publicado: (2022) -
The Chinese Herb Yi-Qi-Huo-Xue Protects Cardiomyocyte Function in Diabetic Cardiomyopathy
por: Wang, Xiangsheng, et al.
Publicado: (2018) -
Influence of ShuJinHuoXue Tablets on Ischemia Reperfusion Injury of Animals’ Skeletal Muscle
por: Tong, Zhihong, et al.
Publicado: (2012) -
Evaluation of HuoXueHuaYu therapy for nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trial
por: Cai, Yunfei, et al.
Publicado: (2019)